Cargando…
The efficacy and adverse effects of budesonide in remission induction treatment of autoimmune hepatitis: a retrospective study
AIM: To compare the early biochemical response and rate of adverse effects in patients who received prednisolone (PRED)/azathioprine (AZA) and those who received budesonide (BUD)/AZA as the first-line treatment for autoimmune hepatitis. METHODS: The study involved 25 patients receiving PRED 30 mg/da...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Croatian Medical Schools
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734566/ https://www.ncbi.nlm.nih.gov/pubmed/31483120 http://dx.doi.org/10.3325/cmj.2019.60.345 |